SOMAÍ Pharmaceuticals | Founder and CEO
medicalcannabis, biotechnology, manufacturing, pharmtech
Michael Sassano is one of the most respected executives in the pharmaceutical cannabis space today. He was an early investor in the cannabis industry in the United States; today, he is celebrated in mainstream business and biopharma media as an international authority on developing large-scale cannabis infrastructures worldwide and the most advanced pharmaceutical cannabinoid products. Michael is also widely respected for successfully predicting long-term cannabis market trends and movements, which he generously shares in many forums. He is well known for leading a merger of the cannabis cultivation company he built and operated, Solaris Farms, with The Sanctuary. Over the last few years, Michael has shifted focus to his role as CEO and Chairman of the Board for SOMAÍ Pharmaceuticals LTD, a European pharmaceutical and biotech company centered on manufacturing in Lisbon, Portugal, and distribution of EU GMP-certified cannabinoid-containing pharmaceuticals throughout the EU.